Terremoto Biosciences

San Francisco, United States

Terremoto Biosciences is a biotechnology company leveraging the power of lysine-based covalency to develop optimized medicines.

Apr 2026

Series C

Biotechnology

Top Investors

RA Capital ManagementCormorant Asset ManagementNovo HoldingsOrbiMedOUP (Osage University Partners)

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Terremoto Biosciences

Who are Terremoto Biosciences's investors?

Terremoto Biosciences's investors include RA Capital Management, Cormorant Asset Management, Novo Holdings, OrbiMed, OUP (Osage University Partners).

Where is Terremoto Biosciences headquartered?

Terremoto Biosciences is headquartered in San Francisco, United States.

What does Terremoto Biosciences do?

Terremoto Biosciences is a biotechnology company leveraging the power of lysine-based covalency to develop optimized medicines.

What stage is Terremoto Biosciences at?

Terremoto Biosciences is at the Series C stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 15, 2026.

MLA

"Terremoto Biosciences — Funding & Investors." VCBacked, April 15, 2026, https://www.vcbacked.co/company/terremoto-biosciences. Accessed June 3, 2026.

APA

VCBacked. (2026). Terremoto Biosciences — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/terremoto-biosciences

Wikipedia (cite web)

{{cite web |title=Terremoto Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/terremoto-biosciences |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 15, 2026.